Peptides by goal · Weight, muscle and energy
Peptides for energy and mitochondria, ranked by evidence
Checked against our library and study pagesPublished by PepVault
Of the 8 compounds in our library linked to energy and mitochondria, 6 have been studied in people for it, 1 has animal or lab evidence only, and 1 rests on community reports alone. NAD+ ranks first, with 5 of our study pages in people on energy and mitochondria.
Peptides and energy and mitochondria
The energy peptides target the mitochondria, the parts of each cell that turn food into usable energy, or mimic some effects of exercise. Several have human trials in people with a disease; most of the exercise-like results are from mice.
For energy, a trial in a mitochondrial disease or an endurance result in mice is a long way from feeling more energetic day to day, so check who was studied and what was measured.

Model. Individual results vary.
The 8 compounds, ranked by evidence
Studied in people
6 compounds
NAD+
#1 · Human studiesNAD+ is a coenzyme every cell needs to turn food into usable energy, and the molecule your sirtuin "longevity" enzymes and DNA-repair machinery run on. Commonly reported: a lift in energy and mental clarity within days, and flushing or nausea when it goes in too fast. For energy and mitochondria it has been studied in people: 5 of our study pages in people are about it.
NAD+ improved LVEF at 1 month in ischemic heart failureOur study page: randomized trial in people, 180 people, 2026
- NAD+: NR and NMN, not nicotinamide, raised blood NAD+ in 14 days
- NMN (MIB-626) raised blood NAD levels in older adults over 14 days
- NAD+ rose with nicotinamide riboside in a 6-week crossover trial
Why it is here: its library entry lists “Cellular energy” and “Mitochondrial support” and 5 of our study pages are about this goal.
NMN
#2 · Human studiesA direct precursor to NAD+, a molecule essential for cellular energy, DNA repair, and the activity of longevity-linked sirtuin enzymes. NAD+ falls in some tissues with age, and NMN reliably raises blood NAD+; small trials show modest, inconsistent functional effects. For energy and mitochondria it has been studied in people: 3 of our study pages in people are about it.
NMN: raised blood NAD over 60 days in 80 middle-aged adultsOur study page: randomized trial in people, 80 people, 2023
- NMN supplements raised blood NAD+ levels in healthy older men
- NMN (MIB-626) raised blood NAD levels in older adults over 14 days
Why it is here: its library entry lists “NAD+ boost” and “Cellular energy” and 3 of our study pages are about this goal.
SS-31
#3 · Human studiesA mitochondria-targeting peptide that binds directly to cardiolipin — a key lipid in the inner mitochondrial membrane where your cells generate energy. FDA-approved in 2025 as elamipretide (Forzinity) for the rare disease Barth syndrome; trials in mitochondrial myopathy and heart failure missed their main goals. For energy and mitochondria it has been studied in people: 2 of our study pages in people are about it.
SS-31: no gain in walk distance or fatigue in the MMPOWER-3 trialOur study page: randomized trial in people, 218 people, 2023
Why it is here: its library entry lists “Mitochondrial repair” and “Energy production” and 2 of our study pages are about this goal.
Dulaglutide
#4 · Human studiesA weekly GLP-1 pen (Trulicity) for type 2 diabetes: it lowers blood sugar and, in people at cardiovascular risk, the combined risk of heart attack, stroke and cardiovascular death, and it comes in four ready-dosed pens. For energy and mitochondria it has been studied in people: 1 of our study pages in people is about it.
GHRP-2 plus L-arginine gave the biggest GH rise during exerciseOur study page: clinical trial in people, 2000
Why it is here: 1 of our study pages is about this goal.
GHRP-2
#5 · Human studiesA potent growth hormone secretagogue: more potent than Ipamorelin but less selective, so along with GH and IGF-1 it also raises cortisol and prolactin. For energy and mitochondria it has been studied in people: 1 of our study pages in people is about it.
GHRP-2 plus L-arginine gave the biggest GH rise during exerciseOur study page: clinical trial in people, 2000
Why it is here: 1 of our study pages is about this goal.
MOTS-c
#6 · Human studiesA peptide encoded by your mitochondrial DNA, the energy-producing organelles inside every cell. In mice it activates AMPK, the pathway exercise triggers, improving insulin sensitivity and exercise capacity, which is why it's called an "exercise mimetic". For energy and mitochondria it has been studied in people: 1 of our study pages in people is about it, beside 1 animal or lab study (rats).
MOTS-c rose after 16 weeks of exercise in non-Hispanic White survivorsOur study page: randomized trial in people, 2021
Why it is here: its library entry lists “Exercise mimetic” and “Energy” and 2 of our study pages are about this goal.
Animal or lab studies only
1 compound
SLU-PP-332
#7 · Animal or labAn experimental "exercise mimetic": a small molecule (not a peptide) from a St. Louis-based academic team that switches on the ERR receptors behind mitochondria and endurance. These receptors run the genes behind mitochondria, fat burning and endurance in muscle, so in mice it mimics parts of aerobic training: more oxidative muscle fibers, more energy expenditure and longer treadmill runs. For energy and mitochondria the evidence is from animals or cells only: 1 study page of ours, in mice.
SLU-PP-332 increased exercise endurance in miceOur study page: animal study in mice, 2023
Why it is here: its library entry lists “Exercise mimetic” and “Endurance (mice)” and 1 of our study pages is about this goal.
Community reports only
1 compound
5-Amino-1MQ
#8 · Reports onlyA small molecule (not a peptide) that blocks the NNMT enzyme in fat cells, which raises NAD+ and pushes fat cells toward burning energy. In cultured fat cells it raises NAD+ and SAM levels; in obese mice it cut body weight and fat without reducing food intake, and with a reduced-calorie diet lean mass made up a larger share of body weight. For energy and mitochondria it rests on community reports: no study page of ours covers this goal, and the library lists it under “NAD+ boost”.
Why it is here: its library entry lists “NAD+ boost”.
How they differ
Route, dosing frequency and half-life as each library entry records them, for the 8 compounds in ranked order.
| Compound | Evidence | Route | Dosing frequency | Half-life |
|---|---|---|---|---|
| NAD+ | Human studies | SubQ injection, IV infusion, Intranasal | Daily or EOD | Minutes |
| NMN | Human studies | Oral, Oral sublingual (for better absorption) | Daily | Short |
| SS-31 | Human studies | SubQ injection | Daily | Short |
| Dulaglutide | Human studies | SubQ injection | Weekly | ~5 days |
| GHRP-2 | Human studies | SubQ injection | 2–3x daily | ~30 min |
| MOTS-c | Human studies | SubQ injection, IM injection | 2–3× weekly | Hours |
| SLU-PP-332 | Animal or lab | Oral capsule | Daily | Unknown: never measured in people |
| 5-Amino-1MQ | Reports only | Oral | Daily | Unknown |
- Evidence
- Human studies
- Route
- SubQ injection, IV infusion, Intranasal
- Dosing
- Daily or EOD
- Half-life
- Minutes
- Evidence
- Human studies
- Route
- Oral, Oral sublingual (for better absorption)
- Dosing
- Daily
- Half-life
- Short
- Evidence
- Human studies
- Route
- SubQ injection
- Dosing
- Daily
- Half-life
- Short
- Evidence
- Human studies
- Route
- SubQ injection
- Dosing
- Weekly
- Half-life
- ~5 days
- Evidence
- Human studies
- Route
- SubQ injection
- Dosing
- 2–3x daily
- Half-life
- ~30 min
- Evidence
- Human studies
- Route
- SubQ injection, IM injection
- Dosing
- 2–3× weekly
- Half-life
- Hours
- Evidence
- Animal or lab
- Route
- Oral capsule
- Dosing
- Daily
- Half-life
- Unknown: never measured in people
- Evidence
- Reports only
- Route
- Oral
- Dosing
- Daily
- Half-life
- Unknown
Compared side by side
Questions
Which peptides have been studied in people for energy and mitochondria?
6 of the 8 on this page: NAD+, NMN, SS-31, Dulaglutide, GHRP-2 and MOTS-c. The rest have animal or lab evidence or community reports only.
Is any peptide FDA-approved for energy and mitochondria?
No. None of the 8 compounds on this page has an FDA approval for a use related to energy and mitochondria in its library entry.
Which is the best-studied peptide for energy and mitochondria?
By our count, NAD+, with 5 study pages in people about energy and mitochondria, the most of any compound here.
Which ones have only animal or lab evidence for energy and mitochondria?
1 compound: SLU-PP-332 (mice). A result in animals or cells often doesn’t hold in people.
How are the peptides for energy and mitochondria taken?
Of the 8 compounds for energy and mitochondria, 5 are taken by injection, 3 by mouth, 1 as a nasal spray, as their library entries list (some have more than one route). The table above gives each one’s route, how often it is dosed and its half-life.
How do the peptides for energy and mitochondria compare with each other?
We compare 4 pairs of them side by side: MOTS-c vs SS-31, MOTS-c vs SLU-PP-332, NAD+ vs NMN and NAD+ vs MOTS-c.
How we ranked them
Each compound is placed on the highest rung its evidence for this goal reaches. First come compounds the FDA has approved for a use related to the goal, and only where the library entry says so. Next come compounds studied in people for it (in one of our study pages, or in the trials a research note of the library entry rests on), then those with animal or lab studies only, and last those resting on community reports alone.
Within a rung, compounds are ordered by how many of our study pages in people cover the goal, then by the library’s overall research rating, then by the number of study pages of any kind. A compound is on this page only because its library entry lists a use for this goal, says so in its description, or one of our study pages is about it; the reason is printed with each one.
This is a ranking of evidence, not of results, and not advice on what anyone should take.